A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

Thank you - Your Download is Available Below

A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

PDF | 1013.2 KB

A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

This article published in BioProcess International describes a scale-up approach that enables faster and more cost-effective manufacture of biologics in fed-batch cultures. It highlights a scaling methodology with a range of single-use bioreactors (15mL to 200L) from process development with Ambr^® bioreactors, through to pilot & manufacturing with Biostat^® STR bioreactors.

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

A Rapid, Low-Risk Approach for Process Transfer of Biologics From Development to Manufacturing Scale

Please Complete the Form

Complete Form to Access the File